Skip to main content
. 2020 Jul;21(7):2091–2098. doi: 10.31557/APJCP.2020.21.7.2091

Table 2.

Genotypic Distribution of TP53 (codon 72) and XPD (codon 751) in the Study Subject and Risk of Lung Cancer

Gene Genotype Control (n=200)
n (%)
Patient (n= 180)
n (%)
OR (95% CI) P-value
TP53 Arg/Arg 74 (37.00) 66 (36.67) 1.0 (Ref.)
Arg/Pro 116 (58.00) 101 (56.11) 0.976 (0.64-1.50) 0.914
Pro/ Pro 10 (5.00) 13 (7.22) 1.458 (0.60-3.55) 0.501
XPD Lys/Lys 103 (51.50) 80 (44.44) 1.0 (Ref.)
Lys/Gln 88 (44.00) 75 (41.67) 1.097 (0.72-1.68) 0.745
Gln/Gln 9 (4.50) 25 (13.89) 3.576 (1.58-8.09) 0.002*

Odds ratios (OR) and 95% confidence interval (95%CI); *p<0.05 considered as level of significance.